Clinical Trials Logo

Clinical Trial Summary

In summary, this piot study with 6 participants shown that recombinant human growth hormone (rhGH) has a positive effect on the treatment with PMS. In addition, This study indicated that rhGH can improve PMS symptoms via increase the level of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP-3). RhGH may be low cost, more accessible, alternative treatment for PMS.


Clinical Trial Description

Compared with the placebo, rhGH treatment significantly decreased the total scores and subscale scores of GDS (P <0.05), while the total scores and subscale scores of SC-ABC significantly decreased (P < 0.05) following three-months rhGH treatment. The similar results were also observed in comparison with baseline. Compared with the baseline, the level of serum IGF-1 and IGFBP-3 increased significantly (P < 0.05) following three-months rhGH treatment, while the placebo group had no significant impact on serum IGF-1 and IGFBP-3 (P > 0.05). One participant developed skin allergy the day after the first rhGH treatment, which were resolved later. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05105685
Study type Interventional
Source Affiliated Hospital of Jiangnan University
Contact
Status Completed
Phase Phase 1/Phase 2
Start date June 14, 2020
Completion date June 8, 2021

See also
  Status Clinical Trial Phase
Completed NCT02987868 - Effects of an Amino Acid-Based hGH Secretagogue on Triiodythyronine N/A
Recruiting NCT03431727 - Acromegaly - Before and After Treatment
Completed NCT03038594 - Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients Phase 2/Phase 3
Completed NCT03203356 - Adrenal Function in GHD Children N/A
Completed NCT02782221 - Lipolytic Effects of GH in Human Subjects in Vivo N/A
Completed NCT05195437 - Evolution of the Quality of Life of Short Statured Children Treated With Growth Hormone : Evaluation at Adult Size
Completed NCT04244123 - Web-based Adherence Information Integrated Nurse-led Monitoring Clinic
Not yet recruiting NCT03005561 - Detection of Difficulties and Improvement Compliance to Growth Hormone Treatment N/A
Recruiting NCT06448195 - Effects of Growth Hormone Therapy on Metabolic Function in Fatty Liver Post-Pituitary Adenoma Surgery Phase 4
Completed NCT03033121 - Three-times-weekly Versus Daily Growth Hormone (GH) Treatment in naïve GH-deficient Children Phase 3
Not yet recruiting NCT05660356 - Growth Hormone Deficiency in Mild Traumatic Brain Injury Early Phase 1
Active, not recruiting NCT00867971 - Is Recombinant Growth Hormone Therapy Associated With Increased Intraoccular Pressure? N/A
Recruiting NCT05253287 - Growth Hormone in Decompensated Liver Cirrhosis Phase 2/Phase 3
Active, not recruiting NCT03091374 - Impact of Recombinant Human Growth Hormone on HIV Persistence Phase 2
Not yet recruiting NCT02326610 - Early hGH Treatment of SGA Infants to Prevent Irreversible Neurologic and Psychological Damage and Sequelae Phase 2
Recruiting NCT06103513 - Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children Phase 3
Recruiting NCT04938466 - Assessment of Adherence, Quality of Life, Clinical Response and Safety of Daily and Long-Acting Growth Hormone Therapy
Recruiting NCT06037473 - The Efficacy and Safety of PEGylated GH for the Treatment of Short Stature in Chinese Children-GLOBE Reg
Recruiting NCT05144035 - A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants Phase 4
Recruiting NCT03878992 - Effects of Growth Hormone and IGF-1 on Anabolic Signals and Stem Cell Recruitment in Human Skeletal Muscle N/A